Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 USD | -8.57% | -11.11% | -46.67% |
May. 03 | North American Morning Briefing : Apple, Amgen -2- | DJ |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 74.39 | 121.5 | 95.17 | 140.4 | 103.4 | 4.194 |
Enterprise Value (EV) 1 | 27.54 | 91.04 | 74.88 | 101.6 | 52.43 | -6.607 |
P/E ratio | -3.62 x | -3.09 x | -4.02 x | -4.08 x | -4.77 x | -0.06 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -1.05 x | -2.94 x | -2.7 x | -2.98 x | -1.11 x | 0.12 x |
EV / FCF | -1.89 x | -5.82 x | -4.21 x | -5.62 x | -2.14 x | 0.38 x |
FCF Yield | -53% | -17.2% | -23.7% | -17.8% | -46.8% | 265% |
Price to Book | 2.38 x | 21.9 x | 6.12 x | 11.1 x | 2.1 x | -0.39 x |
Nbr of stocks (in thousands) | 92.1 | 99.3 | 192 | 348 | 492 | 546 |
Reference price 2 | 808.0 | 1,224 | 496.6 | 404.0 | 210.4 | 7.680 |
Announcement Date | 3/15/18 | 3/14/19 | 3/18/20 | 3/30/21 | 3/25/22 | 3/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -26.18 | -30.97 | -27.7 | -34.07 | -47.12 | -56.74 |
EBIT 1 | -26.36 | -31.12 | -27.87 | -34.24 | -47.26 | -56.89 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -15.52 | -37.68 | -12.79 | -28.16 | -20.28 | -65.15 |
Net income 1 | -15.52 | -37.68 | -12.79 | -28.16 | -20.28 | -65.15 |
Net margin | - | - | - | - | - | - |
EPS 2 | -223.3 | -396.4 | -123.6 | -98.95 | -44.12 | -125.0 |
Free Cash Flow 1 | -14.59 | -15.64 | -17.78 | -18.08 | -24.51 | -17.53 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/15/18 | 3/14/19 | 3/18/20 | 3/30/21 | 3/25/22 | 3/31/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -10.71 | -11.69 | -14.08 | -15.98 | -20.03 | -14.18 | -6.703 | -8.858 | -7.975 | -6.677 |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -5.396 | -5.292 | -4.399 | -20.16 | -18.09 | -17.07 | -9.839 | -1.371 | -7.568 | -5.359 |
Net income 1 | -5.396 | -5.292 | -4.399 | -20.16 | -18.09 | -17.07 | -9.839 | -1.371 | -7.568 | -5.359 |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -11.20 | -10.40 | -8.800 | -40.80 | -36.80 | -34.40 | -16.14 | -0.6900 | -1.940 | -0.5000 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 8/13/21 | 11/15/21 | 3/24/22 | 5/16/22 | 8/15/22 | 11/14/22 | 3/31/23 | 5/15/23 | 8/14/23 | 11/14/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 46.9 | 30.5 | 20.3 | 38.9 | 51 | 10.8 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -14.6 | -15.6 | -17.8 | -18.1 | -24.5 | -17.5 |
ROE (net income / shareholders' equity) | -61.2% | -205% | -121% | -200% | -65.4% | -347% |
ROA (Net income/ Total Assets) | -37.5% | -46.8% | -51.3% | -49.7% | -50.1% | -81.3% |
Assets 1 | 41.35 | 80.46 | 24.93 | 56.66 | 40.47 | 80.11 |
Book Value Per Share 2 | 339.0 | 55.80 | 81.10 | 36.30 | 100.0 | -19.90 |
Cash Flow per Share 2 | 76.00 | 83.80 | 126.0 | 44.50 | 33.90 | 15.00 |
Capex | - | 0.13 | 0.02 | - | - | 0.06 |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/15/18 | 3/14/19 | 3/18/20 | 3/30/21 | 3/25/22 | 3/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-46.67% | 171K | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CFRXQ Stock
- Financials ContraFect Corporation